Wuxi AppTec Co Ltd

WX8

Company Profile

  • Business description

    Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by PRC, Europe, and other regions.

  • Contact

    288 Fute Zhong Road
    Waigaoqiao Free Trade Zone
    Pudong New Area
    Shanghai200131
    CHN

    T: +86 2150461111

    https://www.wuxiapptec.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2026

    Employees

    33,834

Stocks News & Analysis

stocks

Big-four bank earnings surge but revenue growth elusive

Shares sell off after results.
stocks

This ASX supermarkets business is now underperforming its largest competitor

Competition restrains long-term margins.
stocks

Apple earnings: Let the iPhone 17 cycle rip

We raise our fair value estimate for Apple stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,923.8030.30-0.34%
CAC 408,072.0142.83-0.53%
DAX 4024,350.8358.450.24%
Dow JONES (US)49,499.27152.87-0.31%
FTSE 10010,363.9314.89-0.14%
HKSE26,095.88319.351.24%
NASDAQ25,114.44222.130.89%
Nikkei 22559,513.12228.200.38%
NZX 50 Index13,097.6858.480.45%
S&P 5007,230.1221.110.29%
S&P/ASX 2008,697.1028.50-0.33%
SSE Composite Index4,112.164.650.11%

Market Movers